Case report: Pallidal deep brain stimulation for treatment of tardive dystonia/dyskinesia secondary to chronic metoclopramide medication

Case report: Pallidal deep brain stimulation for treatment of tardive dystonia/dyskinesia secondary to chronic metoclopramide medication

ObjectivesTardive dystonia/dyskinesia (TDD) occurs as a side effect of anti-dopaminergic drugs, including metoclopramide, and is often refractory to medication. While pallidal deep brain stimulation (DBS) has become an accepted treatment for TDD secondary to neuroleptic medication, there is much les...

Full description

Bibliographic Details
Main Authors:	Johanna M. Nagel, Joseph Ghika, Joachim Runge, Marc E. Wolf, Joachim K. Krauss
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Neurology
Subjects:	pallidal DBS metoclopramide tardive dystonia tardive dyskinesia GPi DBS case report
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.1076713/full

Similar Items

Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?
by: Hu JB, et al.
Published: (2017-08-01)

Metoclopramide in Gastroparesis: Its Mechanism of Action and Safety Profile
by: M Ammar Kalas, et al.
Published: (2023-08-01)

Tardive dyskinesia
by: Violetta A. Tolmacheva
Published: (2021-11-01)

Tardive dyskinesia on clozapine: A case report
by: Laila Asmal
Published: (2009-03-01)

Tardive dyskinesia in an 8-year old child
by: W. M.M.L. Chandradasa, et al.
Published: (2014-12-01)

Olanzapine induced tardive dyskinesia
by: Rudraprosad Chakraborty, et al.
Published: (2014-01-01)

An investigation on the relationship between risk factors and severity of tardive dyskinesia
by: Y Kalafi, et al.
Published: (1993-12-01)

Drug-induced tardive dyskinesia
by: T. M. Ostroumova, et al.
Published: (2020-02-01)

MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia
by: Dong Xu, et al.
Published: (2017-12-01)

Tardive Dyskinesia in Older Persons Taking Antipsychotics
by: Citrome L, et al.
Published: (2021-10-01)

Tardive Dyskinesia and Treatment Approaches
by: Mehmet Emin Demirkol, et al.
Published: (2018-06-01)

Facial mask masking tardive dyskinesia
by: I. Ganhao
Published: (2021-04-01)

Lurasidone-induced tardive dyskinesia
by: Shreyas Shrikant Pendharkar, et al.
Published: (2022-01-01)

A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report
by: Okamoto N, et al.
Published: (2021-04-01)

The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
by: Robert H. Farber, et al.
Published: (2024-01-01)

Tardive dystonia with olanzapine: A rare case report
by: Gurvinder Pal Singh, et al.
Published: (2012-01-01)

Deep Brain Stimulation in the Treatment of Tardive Dyskinesia
by: Adrianna Szczakowska, et al.
Published: (2023-02-01)

Successful Treatment of Tardive Diaphragmatic Flutter in an Elderly Man with Aripiprazole
by: Yi-Hsiang Chen, et al.
Published: (2013-06-01)

Long-term efficacy of pallidal deep brain stimulation in tardive dystonia: A case report and follow-up of 4 years
by: Shreyashi Jha, et al.
Published: (2023-01-01)

Neuroleptic-induced tardive dystonia in young patients suffering from psychosis
by: Amey Yeshwant Angane, et al.
Published: (2022-01-01)

Tardive dyskinesia: Prevention and newer management strategies
by: Sreelakshmi Vaidyanathan, et al.
Published: (2020-01-01)

Tardive Oromandibular Dystonia Induced by Trazodone: A Clinical Case and Management from the Perspective of the Dental Specialist
by: Nicolás P. Skarmeta, et al.
Published: (2022-09-01)

A case of tardive dyskinesia with paliperidone palmitate
by: Philip Kumar Boyanapally, et al.
Published: (2015-01-01)

Tardive dystonia improved with discontinuation of trazodone in an elderly schizophrenia patient: a case report
by: Yoshinori Kadota, et al.
Published: (2020-04-01)

Risperidone induced tardive movements in an elderly male-a case of cognitive decline masked by behavioral abnormalities
by: Vishnupriya Veeraraghavan, et al.
Published: (2022-12-01)

Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia
by: Olga Yu. Fedorenko, et al.
Published: (2022-06-01)

Reliability and clinical utility of a Portuguese version of the Abnormal Involuntary Movements Scale (AIMS) for tardive dyskinesia in Brazilian patients
by: H. Tonelli, et al.
Published: (2003-04-01)

How to conquer tardive dyskinesia: could pharmacogenetics and therapy drug monitoring be useful tools?
by: Dino Žujić, et al.
Published: (2023-01-01)

Drug-Induced Movement Disorders and Its Associated Factors Among Patients Attending Treatment at Public Hospitals in Eastern Ethiopia
by: Misgana T, et al.
Published: (2020-08-01)

Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021-07-01)

Pallidal deep brain stimulation for KMT2B related dystonia in an Indian patient
by: Roopa Rajan, et al.
Published: (2021-01-01)

Psychotropic Medications-Induced Tardive Dyskinesia and Associated Factors Among Patients with Mental Illness in Ethiopia
by: Kumsa A, et al.
Published: (2020-12-01)

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
by: Ivan V. Pozhidaev, et al.
Published: (2020-04-01)

Severe tardive dystonia on low dose short duration exposure to atypical antipsychotics: Factors explored
by: Nilanjan C Chandra, et al.
Published: (2017-01-01)

Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications
by: Anuradha Baminiwatta, et al.
Published: (2023-06-01)

Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
by: Francois-Pierre Joubert, et al.
Published: (2021-01-01)

Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
by: Solmi M, et al.
Published: (2018-05-01)

Abdominal Wall Dyskinesia: Case Report
by: Leyla Cavdar, et al.
Published: (2020-02-01)

Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia
by: Claassen Daniel O. MD, et al.
Published: (2023-10-01)

Tardive Dyskinesia After Aripiprazole Treatment That Improved With Tetrabenazine, Clozapine, and Botulinum Toxin
by: Lourdes Aguilar, et al.
Published: (2019-03-01)